ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 271 filers reported holding ICU MED INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $396,069 | -17.3% | 2,401 | +16.8% | 0.00% | -50.0% |
| Q3 2021 | $479,000 | -19.2% | 2,056 | -28.8% | 0.00% | -33.3% |
| Q1 2021 | $593,000 | -80.7% | 2,887 | -82.7% | 0.00% | -86.4% |
| Q2 2020 | $3,073,000 | +5021.7% | 16,671 | +5494.3% | 0.02% | +2100.0% |
| Q1 2020 | $60,000 | -98.7% | 298 | -98.3% | 0.00% | -97.3% |
| Q2 2019 | $4,521,000 | -34.9% | 17,945 | -38.2% | 0.04% | +12.1% |
| Q1 2019 | $6,944,000 | -63.9% | 29,014 | -65.4% | 0.03% | -83.2% |
| Q4 2018 | $19,253,000 | -77.8% | 83,842 | -72.6% | 0.20% | -46.6% |
| Q3 2018 | $86,668,000 | +3308.1% | 306,520 | +1423.5% | 0.37% | +1950.0% |
| Q3 2016 | $2,543,000 | -83.3% | 20,120 | -85.1% | 0.02% | -85.9% |
| Q2 2016 | $15,273,000 | +29.3% | 135,456 | +19.4% | 0.13% | +12.3% |
| Q1 2016 | $11,809,000 | -8.6% | 113,437 | -1.0% | 0.11% | -5.8% |
| Q4 2015 | $12,920,000 | +133.4% | 114,554 | +126.6% | 0.12% | +77.9% |
| Q3 2015 | $5,535,000 | +1181.2% | 50,551 | +600.2% | 0.07% | +750.0% |
| Q1 2014 | $432,000 | – | 7,219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |